IGF1 and ovarian carcinoma: Specific neutralizing antibodies directed against four agents known from the literature to cause EMT—that is, EGF, HGF, IGF-1, and TGF-β1—were added to the malignant ascites to establish whether some of these agents may be responsible for EMT development in ovarian cancer cells.